This quarterly is fine, and should mark the low point. Cash outflow, ex USA, will reduce going forward, R&D tax credit of $4.8m, first benefits of restructuring, and more to come if R&D outsourced.
The Investor Briefing provides a more positive story than the bare numbers are telling.
There are good raesons why it's not $3, or even $1.35 anymore, but, down at 13c, the baby has well and truly been thrown out with the bathwater.
Positive announceemnts in Q4 should take this stock back to 40c without any trouble, IMO.
appendix 4c - quarterly, page-4
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.3¢ |
Change
-0.001(2.94%) |
Mkt cap ! $39.40M | |||
| Open | High | Low | Value | Volume |
| 3.4¢ | 3.4¢ | 3.2¢ | $46.51K | 1.381M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 186766 | 3.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 196199 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| SNT (ASX) Chart |